智通财经APP讯，中金辐照(300962.SZ)发布2025年度向特定对象发行A股股票预案，本次发行的发行对 象为包括中国黄金集团在内不超过35名(含35名)符合中国证监会规定条件的特定对象，公司控股股东中 国黄金集团以人民币1亿元认购公司本次发行的股票。 本次发行的募集资金总额不超过人民币8亿元(含本数)，扣除相关发行费用后的募集资金净额拟用于以 下项目：中金辐照长沙灭菌技术服务中心项目、合肥市综合灭菌技术中心项目、中金健康科技(嘉兴)有 限公司年灭菌医疗器械30万立方米项目二期、钴源采购项目以及补充流动资金。 ...

Group 1: Company Overview - The company is a member of the International Irradiation Association and serves as the vice-chairman unit of the China Isotope and Radiation Association, being one of the earliest enterprises to industrialize irradiation technology in China [2][3] - It has developed into one of the most specialized irradiation sterilization companies in China, with the highest cobalt source activity and the most comprehensive network layout [3] Group 2: Equipment and Technology - The company owns gamma and electron accelerator irradiation devices in cities including Shenzhen, Shanghai, Tianjin, Qingdao, Wuhan, Chengdu, Chongqing, Jiaxing, and Changsha (under construction) [2] - Gamma irradiation is noted for its strong penetration, wide application, and low carbon environmental benefits, while electron accelerators are recognized for their high efficiency and controllable radiation [2] Group 3: Production Capacity and Expansion - The company has sufficient cobalt sources to meet continuous operational demands and can expand production capacity based on market needs [2][3] - Future capacity expansion may involve supplementing cobalt sources in existing facilities or adding new devices at current and new sites [2] Group 4: Financial Performance - The company's gross margin is influenced by production scale, product structure, irradiation pricing, and production costs, with rising cobalt procurement prices impacting costs [3] - The company plans to enhance gross margin through diversified sourcing, optimizing product structure, and strengthening cost control [3] Group 5: Customer Base and Market Position - The top five customers account for approximately 14.81% of total annual sales, with each contributing around 3%, indicating low customer concentration [3] - The company maintains long-term strategic partnerships across various industries, including healthcare, food, pharmaceuticals, daily necessities, and packaging materials [3] Group 6: Future Financing Plans - The company has a low debt-to-asset ratio and plans to use a mix of equity and debt financing to support its development needs [3]